December 3, 2022
Loading...
You are here:  Home  >  'Food and Drug Administration'
Latest

FDA gives big win to Amgen in biosimilars race

By   /  Friday, September 30th, 2016  /  East Ventura County, Health Care & Life Science, Latest news  /  Comments Off on FDA gives big win to Amgen in biosimilars race

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Certification gives Apeel appeal

By   /  Friday, July 22nd, 2016  /  Technology, Top Stories, Top Story  /  Comments Off on Certification gives Apeel appeal

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

FDA declines to approve Novartis biosimilar for Amgen’s Neulasta

By   /  Tuesday, July 19th, 2016  /  Health Care & Life Science, Latest news  /  Comments Off on FDA declines to approve Novartis biosimilar for Amgen’s Neulasta

The Food and Drug Administration has declined for now to approve a copycat version of Amgen’s blockbuster drug Neulasta. Reuters reported July 19 that the FDA sent a letter to Swiss pharmaceutical Novartis at the end of June saying it was declining to approve the drug for now. Neulasta, made by Thousand Oaks-based biotech giant Read More →

Latest

Santa Maria firm sued over role in listeria outbreak

By   /  Friday, November 2nd, 2012  /  Agribusiness, Law & Goverment, Top Stories  /  Comments Off on Santa Maria firm sued over role in listeria outbreak

A Santa Maria company’s subcontractor was the last firm to sign off on the food-safety practices at a farm that produced listeria-laced cantaloupe that led to dozens of deaths throughout the country, several lawsuits allege. PrimusLabs is a third-party food auditor that’s hired by growers to inspect whether their facilities, equipment and practices meet industry Read More →

Latest

Amgen drug shows blockbuster promise

By   /  Friday, May 20th, 2011  /  Technology, Top Stories  /  Comments Off on Amgen drug shows blockbuster promise

Putting test results behind the talk at its recent product pipeline review, Thousand Oaks-based Amgen on May 17 released promising results for the Xgeva variant of its potential blockbuster bone drug denosumab.